Background: Treatment for oropharyngeal squamous cell carcinoma (OPSCC) has changed, as the proportion of human papilloma virus (HPV)-related disease has increased. We evaluated nationwide information on its management and outcome during the treatment paradigm change period.
Methods: We included all patients diagnosed and treated for OPSCC at the five Finnish university hospitals from 2000 to 2009.